Stay updated on Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial page.

Latest updates to the Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial page
- Check2 days agoChange DetectedThe Italy location listing was updated from Padua, Italy, 35128 to Padova, Italy, 35128.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check25 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3, replacing the previous version. This likely reflects a behind-the-scenes maintenance update.SummaryDifference0.0%

- Check54 days agoChange DetectedThe site update introduces revision 3.4.2 and removes the prior funding-status notices (3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check61 days agoChange DetectedAdded a site-wide government funding status notice and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check68 days agoChange DetectedGlossary display added; minor labeling and revision metadata updates were implemented. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial page.